CEFOXITIN SODIUM - CLINICAL AND PHARMACOLOGICAL STUDY

被引:11
作者
REEVES, DS
BINT, AJ
HOLT, HA
STOCKS, PJ
机构
关键词
D O I
10.1093/jac/4.suppl_B.155
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:155 / 160
页数:6
相关论文
共 6 条
[1]  
BARZA M, 1976, INFECTION S2, V4, pS95
[2]  
GIBALDI M, 1968, CLIN PHARMACOL THER, V9, P345
[3]   EFFECTS OF RATE OF INFUSION AND PROBENECID ON SERUM LEVELS, RENAL EXCRETION, AND TOLERANCE OF INTRAVENOUS DOSES OF CEFOXITIN IN HUMANS - COMPARISON WITH CEPHALOTHIN [J].
GOODWIN, CS ;
RAFTERY, EB ;
GOLDBERG, AD ;
SKEGGS, H ;
TILL, AE ;
MARTIN, CM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 6 (03) :338-346
[4]   CEFOXITIN, A NEW SEMI-SYNTHETIC CEPHAMYCIN - IN-VITRO AND IN-VIVO COMPARISON WITH CEPHALOTHIN [J].
KOSMIDIS, J ;
HAMILTON.JM ;
GILCHRIST, JN ;
KERRY, DW ;
BRUMFITT, W .
BMJ-BRITISH MEDICAL JOURNAL, 1973, 4 (5893) :653-655
[5]   COMPARATIVE CLINICAL PHARMACOLOGY OF INTRAVENOUS CEFOXITIN AND CEPHALOTHIN [J].
SONNEVILLE, PF ;
KARTODIRDJO, RR ;
SKEGGS, H ;
TILL, AE ;
MARTIN, CM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 9 (5-6) :397-403
[6]   SUSCEPTIBILITY OF ANAEROBIC BACTERIA TO CARBENICILLIN, CEFOXITIN, AND RELATED DRUGS [J].
SUTTER, VL ;
FINEGOLD, SM .
JOURNAL OF INFECTIOUS DISEASES, 1975, 131 (04) :417-422